PSEN1 and Alzheimer disease: In addition, the intrinsic neuronal excitability was unchanged by the APP/PS1 transgenic background at this age, suggesting synaptic dysfunction underlying CA1 neuronal hyperactivity in the early stage of AD pathophysiology.